Charles River Labs Intl buy UBS Group AG
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€269.47
Performance (%)
-6.85%
Price
09.05.24
€212.20
Summary
This prediction is currently active. With a performance of -6.85%, the BUY prediction for Charles River Labs Intl by UBS_Group_AG is down slightly. This prediction currently runs until 15.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -2.167% | -2.167% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $270.00 to $290.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
33.50%
09.05.24
09.05.24